Full text
PDFPage 227
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carter J. N., Steinbeck K. S. Reduced adrenal androgens in patients with myotonic dystrophy. J Clin Endocrinol Metab. 1985 Mar;60(3):611–614. doi: 10.1210/jcem-60-3-611. [DOI] [PubMed] [Google Scholar]
- Kleerekoper M., Ingham J. P., McCarthy S. W., Posen S. Parathyroid hormone assay in primary hyperparathyroidism: experiences with a radioimmunoassay based on commercially available reagents. Clin Chem. 1974 Mar;20(3):369–375. [PubMed] [Google Scholar]
- Patten B. M., Bilezikian J. P., Mallette L. E., Prince A., Engel W. K., Aurbach G. D. Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med. 1974 Feb;80(2):182–193. doi: 10.7326/0003-4819-80-2-182. [DOI] [PubMed] [Google Scholar]
- Posen S., Clifton-Bligh P., Reeve T. S., Wagstaffe C., Wilkinson M. Is parathyroidectomy of benefit in primary hyperparathyroidism? Q J Med. 1985 Mar;54(215):241–251. [PubMed] [Google Scholar]
- Steinbeck K. S., Carter J. N. Thyroid abnormalities in patients with myotonic dystrophy. Clin Endocrinol (Oxf) 1982 Nov;17(5):449–456. doi: 10.1111/j.1365-2265.1982.tb01612.x. [DOI] [PubMed] [Google Scholar]
- Walsh J. C., Turtle J. R., Miller S., McLeod J. G. Abnormalities of insulin secretion in dystrophia myotonica. Brain. 1970;93(4):731–742. doi: 10.1093/brain/93.4.731. [DOI] [PubMed] [Google Scholar]